Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,116 | 322 | 96.3% |
| Education | $232.59 | 21 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,530 | 88 | $0 (2024) |
| Alkermes, Inc. | $739.08 | 36 | $0 (2024) |
| Corium, LLC | $595.37 | 32 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $545.68 | 27 | $0 (2024) |
| Lundbeck LLC | $472.71 | 25 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $405.93 | 20 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $388.15 | 21 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $373.06 | 29 | $0 (2024) |
| ITI, Inc. | $309.13 | 16 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $302.13 | 18 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,779 | 100 | ABBVIE INC. ($340.47) |
| 2023 | $1,703 | 93 | AbbVie Inc. ($585.00) |
| 2022 | $865.39 | 50 | ABBVIE INC. ($202.62) |
| 2021 | $1,253 | 62 | AbbVie Inc. ($401.62) |
| 2019 | $24.55 | 1 | Otsuka America Pharmaceutical, Inc. ($24.55) |
| 2018 | $150.30 | 7 | Otsuka America Pharmaceutical, Inc. ($57.19) |
| 2017 | $572.60 | 30 | Sunovion Pharmaceuticals Inc. ($245.20) |
All Payment Transactions
343 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Education | In-kind items and services | $11.87 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/16/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Education | In-kind items and services | $11.87 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $23.77 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $28.38 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Neuroscience | ||||||
| 11/26/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/26/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $2.40 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/22/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: CNS | ||||||
| 11/15/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Education | In-kind items and services | $11.87 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/15/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Education | In-kind items and services | $11.87 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/15/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Education | In-kind items and services | $11.87 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/15/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Education | In-kind items and services | $11.87 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/15/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Education | In-kind items and services | $11.87 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/14/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Education | In-kind items and services | $1.20 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/14/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Education | In-kind items and services | $1.20 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/07/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: Neuroscience | ||||||
| 10/31/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: CNS | ||||||
| 10/30/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/21/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Education | In-kind items and services | $1.20 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/21/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Education | In-kind items and services | $1.20 | General |
| Category: SCHIZOPHRENIA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 160 | 638 | $79,960 | $37,527 |
| 2022 | 3 | 235 | 626 | $69,315 | $43,646 |
| 2021 | 2 | 161 | 529 | $69,370 | $49,773 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 111 | 584 | $67,670 | $30,980 | 45.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 33 | 34 | $9,520 | $4,852 | 51.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 20 | $2,770 | $1,695 | 61.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 427 | $32,025 | $24,800 | 77.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 89 | 93 | $26,040 | $14,150 | 54.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 106 | $11,250 | $4,696 | 41.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 83 | 450 | $47,250 | $37,120 | 78.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 78 | 79 | $22,120 | $12,653 | 57.2% |
About Dr. Ricardo Dancel, MD
Dr. Ricardo Dancel, MD is a Psychiatry healthcare provider based in Chelmsford, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164520631.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ricardo Dancel, MD has received a total of $6,348 in payments from pharmaceutical and medical device companies, with $1,779 received in 2024. These payments were reported across 343 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($6,116).
As a Medicare-enrolled provider, Dancel has provided services to 556 Medicare beneficiaries, totaling 1,793 services with total Medicare billing of $130,946. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Chelmsford, MA
- Active Since 09/20/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1164520631
Products in Payments
- VRAYLAR (Drug) $1,530
- REXULTI (Drug) $662.30
- Azstarys (Drug) $488.56
- TRINTELLIX (Drug) $388.15
- INVEGA SUSTENNA (Drug) $378.09
- ARISTADA (Drug) $356.35
- CAPLYTA (Drug) $323.58
- LATUDA (Drug) $302.13
- INGREZZA (Drug) $240.95
- FANAPT (Drug) $191.47
- ABILIFY MAINTENA (Drug) $184.54
- VIVITROL (Drug) $165.98
- Aristada 441 mg (Drug) $121.20
- HETLIOZ (Drug) $114.95
- AZSTARYS (Drug) $106.81
- BRINTELLIX (Drug) $105.96
- AUSTEDO (Drug) $71.81
- ABILIFY ASIMTUFII (Drug) $65.59
- Vivitrol (Drug) $65.36
- UZEDY (Drug) $62.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Chelmsford
Chand Bhan, Md, MD
Psychiatry — Payments: $1,150
James Harburger, Md, MD
Psychiatry — Payments: $124.68
Eugene Kim, Md, MD
Psychiatry — Payments: $14.10
Bruce Holstein, Md, MD
Psychiatry
Dr. Jeffrey Speller, M.d, M.D
Psychiatry
Jonathan Harland, M.d, M.D
Psychiatry